Edition:
United Kingdom

Luye Pharma Group Ltd (2186.HK)

2186.HK on Hong Kong Stock

6.45HKD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
HK$6.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,726,507
52-wk High
HK$9.86
52-wk Low
HK$4.80

Select another date:

Tue, May 8 2018

Photo

AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million

LONDON British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and bipolar disease, to Luye Pharma Group for $538 million (396.8 million pounds), as part of a strategy to focus on other therapy areas.

AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million

LONDON British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and bipolar disease, to Luye Pharma Group for $538 million, as part of a strategy to focus on other therapy areas.

AstraZeneca sells rights for Seroquel to Luye Pharma for $538 mln

LONDON, May 8 British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and bipolar disease, to Luye Pharma Group for $538 million, as part of a strategy to focus on other therapy areas.

BRIEF-Luye Pharma Group Acquires Astrazeneca's Rights Relating To Seroquel And Seroquel XR

* ANNOUNCES ACQUISITION OF ASTRAZENECA'S RIGHTS RELATING TO SEROQUEL AND SEROQUEL XR IN CHINA AND IN OTHER TERRITORIES

Select another date: